Results 141 to 150 of about 213,320 (307)
The Oncologist, EarlyView., 2021 Abstract Background Medullary thyroid cancer (MTC) standard of care includes multikinase inhibitors (MKIs), which can exacerbate disease‐related diarrhea, primarily because of non‐RET kinase inhibition. We report diarrhea and other patient‐reported outcomes (PROs) with selpercatinib, a highly selective RET inhibitor, among patients with RET‐mutant MTC ...
Lori J. Wirth +10 more
wiley +1 more source
Pharmaceutical policy and health economics
Folia Pharmacologica Japonica, 2013 Hiroaki, Kakihara +2 more
openaire +3 more sources
EcoEnergy, EarlyView.This review systematically compares photocatalytic urea synthesis from various C (CO2, CO, CH3OH) and N (N2, NH3, NO3−) sources. It highlights C–N coupling mechanisms, key challenges, and future directions, offering a framework to guide rational catalyst design for sustainable, solar‐driven urea production.
Bo Ding +5 more
wiley +1 more source
Policy Analysis Of Iranian Pharmaceutical Sector; A Qualitative Study
Risk Management and Healthcare Policy, 2019 Farbod Ebadi Fardazar,1 Ali Sarabi Asiabar,2 Hossein Safari,1 Mojgan Asgari,3 Ali Saber,4 Amir Ali Ebadi Fard Azar5 1School of Public Health, Health Promotion Research Center, Iran University of Medical Sciences, Tehran, Iran; 2School of Health ...
Ebadi Fardazar F +5 more
doaj
Defect‐Engineered SrTiO3‐x for Flexoelectric‐Dominated Catalysis
EcoEnergy, EarlyView.Defect‐engineered SrTiO3‐x nanoparticles with enhanced flexoelectricity efficiently degrade pollutants and produce hydrogen under ultrasound‐driven flexocatalysis. This materials–engineering approach offers a scalable pathway for combining environmental remediation and renewable energy applications. ABSTRACT Flexocatalysis provides an alternative route
Yu‐Chun Huang +16 more
wiley +1 more source
Pharmacoeconomic Analysis in Saudi Arabia: An Overdue Agenda Item for Action
Annals of Saudi Medicine, 2011 Pharmacoeconomics is a branch of health economics related to the most economical and efficient use of pharmaceuticals. Pharmacoeconomic research identifies, measures and compares the costs and outcomes (clinical, economic and humanistic) of ...
Al-Jazairi Abdulrazaq +2 more
doaj
ENERGY &ENVIRONMENTAL MATERIALS, EarlyView.This review summarizes recent advances in electrocatalytic sulfide oxidation (SOR), focusing on catalyst design strategies, reaction system engineering, and pathways for high‐value product generation. The roles of different reduced sulfur species (S2−, HS−, H2S) under various industrial conditions are highlighted, along with approaches to enhance ...
Zhongyuan Wang +4 more
wiley +1 more source
Learning Networks Drive Environmental Innovation: Evidence From Fourth‐Stage Purification Diffusion
Environmental Policy and Governance, EarlyView.ABSTRACT Contaminants of emerging concern, including pharmaceuticals and industrial chemicals, threaten water quality globally. In the European Union (EU), until the adoption of the revised Urban Wastewater Treatment Directive in 2024, a regulatory gap had left the member states and the municipalities in them without binding removal standards ...
Simon Bulian +3 more
wiley +1 more source
Risk Management and Healthcare PolicyBo Ding,1 Run Zhao,2 Xinyi Yue,2 Dexun Li2 1Pharmacy Department, Hefei Maternal and Child Health Hospital, Hefei, People’s Republic of China; 2School of Pharmaceutical Economics and Management, Anhui University of Chinese Medicine, Hefei, People’s ...
Ding B, Zhao R, Yue X, Li D
doaj
ESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi +6 more
wiley +1 more source